Yong-Chan Kim
Direktor/Vorstandsmitglied bei BAUDAX BIO, INC.
Vermögen: 32 $ am 31.05.2024
Aktive Positionen von Yong-Chan Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BAUDAX BIO, INC. | Direktor/Vorstandsmitglied | 03.07.2023 | - |
| Independent Dir/Board Member | 03.07.2023 | - | |
TeraImmune, Inc.
 TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | 01.04.2019 | - |
| Vorstandsvorsitzender | 01.04.2019 | - | |
| Gründer | 01.01.2016 | - |
Karriereverlauf von Yong-Chan Kim
Ausbildung von Yong-Chan Kim
| Chungnam National University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Südkorea | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAUDAX BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TeraImmune, Inc.
TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- Yong-Chan Kim
- Erfahrung
